US 8501953
PKM2 modulators for use in the treatment of cancer
granted A61PA61P35/00
Quick answer
US patent 8501953 (PKM2 modulators for use in the treatment of cancer) held by Agios Pharmaceuticals, Inc. expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P35/00